Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Griseofulvin Tablets

Approval Number

国药准字H51022001

Company地奥集团成都药业股份有限公司

Registration Date

December 18, 2020

Previous Approval Numbers

国药准字H51022001

Drug Information

Generic Name

灰黄霉素片

Dosage Form

片剂

Strength

0.1g

Drug Type

化学药品

Registration Date

December 18, 2020

Company Information

Applicant Company

Company Name地奥集团成都药业股份有限公司

Company Address

成都高新区合瑞路518号

Manufacturing Company

Company Name地奥集团成都药业股份有限公司

Company Address

成都市高新区合瑞路518号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy